Pharmaceutical
June 23, 2008
The Associated Press is reporting that a Johnson & Johnson unit recently bought a Swedish company that develops technology for faster diagnostic tests of patient blood samples.J&J, one of the
Read More
June 20, 2008
According to Reuters, China has granted diplomatic approval for the U.S. Food and Drug Administration to open three inspections offices in China that also will help increase China''s capacity for
Read More
June 18, 2008
According to the Associated Press, French pharmaceuticals maker Sanofi-Aventis SA said recently it''s planning a takeover bid for Zentiva that values the Czech generic drugs maker at $2.56 billion.Sanofi-Aventis, which
Read More
June 16, 2008
According to Reuters, Japanese drug maker Daiichi Sankyo said recently its open offer to buy up to 20 percent in India''s Ranbaxy Laboratories would open soon.Daiichi struck a deal last
Read More
June 12, 2008
According to Reuters, Irish drugmaker Elan is likely to separately list its development and manufacturing division Elan Drug Technology (EDT), worth up to $1.5 billion (757 million pounds), if it
Read More
June 9, 2008
Reuters is reporting that Indian drugmaker Cadila Healthcare Ltd. said recently it has acquired 70 percent in South Africa''s Simayla Pharmaceuticals, marking the Indian firm''s second buy in less than
Read More
June 9, 2008
According to Reuters, Western drug agencies need to step up cooperation to head off a repeat of the recent scandal over tainted Heparin and protect patients from counterfeits, Thomas
Read More
June 6, 2008
According to the Associated Press, generic drug developer Mylan Inc. said recently that a subsidiary has entered into a settlement and license agreement with Abbott Laboratories relating to a generic
Read More
June 4, 2008
According to the Associated Press, Swiss pharmaceuticals company Novartis AG said recently it is buying U.S.-based antibiotics developer Protez Pharmaceuticals Inc. for as much as $400 million.Protez, based in Malvern,
Read More
June 2, 2008
The Associated Press is reporting that generic and specialty pharmaceutical company Mylan Inc. said recently it has acquired the central eastern European generics businesses of German drug maker Merck KGaA,
Read More